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Dear Sir,
Protein Z, a vitamin K-dependent plasma glycoprotein, has been
reported to exert an important role in inhibiting coagulation by
acting as cofactor for the inactivation of activated factor X
through the formation of a complex with a protein Z-dependent
protease inhibitor (1). During the last years, low protein Z levels
have been found to be related to cerebral as well as coronary
atherosclerotic diseases (2, 3).Actually, in 2004 Santacroce et al.
demonstrated, in a healthy population, a significant influence of
the protein Z gene 79 G>A polymorphism on protein Z plasma
levels (4). In addition, more recently, two papers reported a poss-
ible relationship between protein Z gene polymorphisms and the
occurrence of ischemic stroke (5, 6).
In order to evaluate the relationship between protein Z gene
polymorphisms (79 G>A; –13 A>G) protein Z levels and acute
coronary syndromes (ACS), we investigated 244 unrelated pa-
tients (188 male; 56 female; median age: 64 years) and 352 (271
males; 81 females; median age: 63 years) age- and sex-com-
parable healthy subjects. Patients were consecutively admitted
for percutaneous coronary intervention at the Catheterization
Laboratory of the Department of Heart and Vessels of the Uni-
versity of Florence. ACS was diagnosed according to criteria es-
tablished by the American College of Cardiology and the Euro-
pean Society of Cardiology (7). The coronary angiography was
performed by the Judkins’ method, and coronary vessels with at
least 75% stenosis were defined as diseased. Acute myocardial
infarction occurred in 120 (49.2%) and unstable angina in 124
(50.8%) patients. Monovessel disease was present in 185
(75.8%) patients, whereas bivessel and trivessel disease was pre-
sent in 51 (20.9%) and 8 (3.3) patients, respectively.
The control group consisted of 352 unrelated subjects re-
cruited from the staff of the University of Florence and from
partners or friends of patients. All subjects gave informed con-
sent; the study complies with the Declaration of Helsinki and
was approved by the local ethic committee. Protein Z levels were
measured by using a commercial assay (Asserachrom Protein Z;
Diagnostica Stago, Asnieres, France). Protein Z gene polymor-
phisms were analysed as previously reported (5). Statistical ana-
lyses were performed by using the SPSS (Statistical Package for
Social Sciences, Chicago, IL, USA) software for Windows (Ver-
sion 12.0). Mann-Whitney test for unpaired data was used for
comparisons between single groups, and the Kruskal-Wallis test
was used for comparisons among different groups. The Chi
2
-test
was used for testing Hardy-Weinberg equilibrium of both poly-
morphisms. Univariate logistic regression analysis was perform-
ed withACS as independent variable to test for an association be-
tween protein Z gene polymorphisms and ACS. Multivariate
model with adjustment for possible confounders was not per-
formed due to the not significant association found in the uni-
variate model. A p-value < 0.05 was considered to indicate stat-
istical significance. Confidence intervals (CI) were calculated at
the 95% level.
Protein Z plasma levels were found to be significantly lower
in patients than in healthy controls (1431.6 ± 758.2 vs. 1738.9 ±
641.6 ng/ml; p<0.0001). Both polymorphisms investigated were
in Hardy-Weinberg equilibrium. Neither genotype distribution
(p=0.3, and p=0.6 for –13 A>G and 79G>A polymorphisms, re-
spectively) nor allele frequency for both polymorphisms was sig-
nificantly different between patients and controls [allele fre-
quency: (-13G: 0.06 vs. 0.08; p=0.3), (79A: 0.20 vs. 0.18; p=0.5)
for patients and controls, respectively]. Protein Z levels were
found to be significantly lower according to the different geno-
types for both polymorphisms, as concerned the presence of the
variant rare alleles (Table 1). As regarding 79 G>A polymor-
phism, the influence of the 79A allele on circulating levels of the
protein is evident within the whole population as well as among
patients and controls taken separately. On the contrary, the –13
A>G polymorphism significantly influenced protein Z levels in
the whole population and in control subjects but not among pa-
tients. Notably, protein Z levels are reported to be significantly
lower in patients compared to controls even within the different
genotypes of the 79 G>A polymorphism. Logistic regression
analysis found no association between rare alleles and ACS
(-13AG+GG: OR 0.8, 95% CI 0.5–1.2, p=0.3; 79GA+AA: OR
1.2, 95% CI 0.8–1.6, p=0.3). Similarly, the contemporary pre-
sence of the two variants was not significantly associated to the
disease (-13AG+GG/79GA+AA: OR 0.9, 95% CI 0.5–1.7,
p=0.8).
We found that rare alleles of polymorphisms encoding the
protein Z gene (intron F 79 G>A and –13 A>G) are not signifi-
cantly associated with the occurrence of ACS. This is at variance
with Lichy et al. (5) and with Staton et al. (6) who reported a sig-
nificant protective effect of the 79A allele of the intron F 79 G>A
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Table 1: Protein Z levels according to genotype distribution for protein Z gene polymorphisms.
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–13 A>G
–13AA 79GA 79AA p
Total
(n=596)
1758.8 ± 739.6
(n=512)
1430.8 ± 726.4
(n=191)
1138.7 ± 893.8
(n=16)
<0.0001
Patients
(n=244)
1736.4 ± 844.1
(n=214)
1193 ± 714.8
(n=84)
611 ± 449.9
(n=6)
<0.0001
Controls
(n=352)
1772.9 ± 655.4^
(n=298)
1617.4 ± 682.5^
(n=107)
1455.4 ± 959.8°
(n=10)
0.02
Data are expressed as mean ± SD. * p=0.03 vs. 79GG patients. ^ p<0.0001 vs. 79GA patients. ° p <0.0001 vs. 79AA patients.
–13AG
1567.5 ± 655.7
(n=84)
1597 ± 850.6
(n=30)
1551.1 ± 526.1
(n=54)
–13GG
-
-
-
p
0.01
0.3
0.01
Intron F 79 G>A
79GG
1722.1 ± 663.8
(n=389)
1593.8 ± 738.2
(n=154)
1806.2 ± 596.9*
(n=235)
